Your browser doesn't support javascript.
loading
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study.
Quarta, Leonardo; Mazzone, Elio; Cannoletta, Donato; Stabile, Armando; Scuderi, Simone; Barletta, Francesco; Cucchiara, Vito; Nocera, Luigi; Pellegrino, Antony; Robesti, Daniele; Leni, Riccardo; Zaurito, Paolo; Brembilla, Giorgio; De Cobelli, Francesco; Samanes Gajate, Ana Maria; Picchio, Maria; Chiti, Arturo; Montorsi, Francesco; Briganti, Alberto; Gandaglia, Giorgio.
Afiliação
  • Quarta L; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Mazzone E; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Cannoletta D; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Stabile A; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Scuderi S; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Barletta F; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Cucchiara V; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Nocera L; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Pellegrino A; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Robesti D; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Leni R; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Zaurito P; Division of Oncology/Unit of Urology, Gianfranco Soldera Prostate Cancer Lab, Urological Research Institute (URI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Brembilla G; Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • De Cobelli F; Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.
  • Samanes Gajate AM; Department of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Picchio M; Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.
  • Chiti A; Department of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Montorsi F; Department of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Briganti A; Vita-Salute San Raffaele University, Via Olgettina 58, 20132, Milan, Italy.
  • Gandaglia G; Department of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Eur J Nucl Med Mol Imaging ; 51(12): 3789-3798, 2024 Oct.
Article em En | MEDLINE | ID: mdl-38861182
ABSTRACT

INTRODUCTION:

Prostate-specific membrane antigen radioguided surgery (PSMA-RGS) might identify lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing extended pelvic lymph node dissection (ePLND). The optimal target-to-background (TtB) ratio to define RGS positivity is still unknown. MATERIALS &

METHODS:

Ad interim analyses which focused on 30 patients with available pathological information were conducted. All patients underwent preoperative PSMA positron emission tomography (PET). 99m-Technetium-PSMA imaging and surgery ([99mTc]Tc-PSMA-I&S) was administered the day before surgery. In vivo measurements were conducted using an intraoperative gamma probe. Performance characteristics and implications associated with different TtB ratios were assessed.

RESULTS:

Overall, 9 (30%) patients had LNI, with 22 (13%) and 80 (11%) positive regions and lymph nodes, respectively. PSMA-RGS showed uptakes in 12 (40%) vs. 7 (23%) vs. 6 (20%) patients for a TtB ratio ≥ 2 vs. ≥ 3 vs. ≥ 4. At a per-region level, sensitivity, specificity and accuracy for a TtB ratio ≥ 2 vs. ≥ 3 vs. ≥ 4 were 72%, 88% and 87% vs. 54%, 98% and 92% vs. 36%, 99% and 91%. Performing ePLND only in patients with suspicious spots at PSMA PET (n = 7) would have spared 77% ePLNDs at the cost of missing 13% (n = 3) pN1 patients. A TtB ratio ≥ 2 at RGS identified 8 (24%) suspicious areas not detected by PSMA PET, of these 5 (63%) harbored LNI, with one pN1 patient (11%) that would have been missed by PSMA PET. Adoption of a TtB ratio ≥ 2 vs. ≥ 3 vs. ≥ 4, would have allowed to spare 18 (60%) vs. 23 (77%) vs. 24 (80%) ePLNDs missing 2 (11%) vs. 3 (13%) vs. 4 (17%) pN1 patients.

CONCLUSIONS:

PSMA-RGS using a TtB ratio ≥ 2 to identify suspicious nodes, could allow to spare > 50% ePLNDs and would identify additional pN1 patients compared to PSMA PET and higher TtB ratios.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Metástase Linfática Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Metástase Linfática Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália